PETBEX Trademark
Trademark Overview
On Tuesday, July 9, 2024, a trademark application was filed for PETBEX with the United States Patent and Trademark Office. The USPTO has given the PETBEX trademark a serial number of 79403242. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, July 15, 2025. This trademark is owned by Brexogen Inc.. The PETBEX trademark is filed in the Pharmaceutical Products category with the following description:
Veterinary preparations for companion animals and non-companion working animals for treatment of inflammatory conditions, including metabolic, autoimmune, and geriatric diseases, and for preserving, supporting, or restoring the function of damaged tissues or organs to promote recovery and normal physiological function; veterinary vaccines; medicated skin treatment for animals in the nature of pharmaceutical preparations for animal skincare for the treatment of dermatitis and wound healing; food supplements for veterinary purposes; medical foodstuff additives for veterinary use for improving nutrition and immune function in animals; biological preparations for medical or veterinary purposes being biological reagents for therapeutic use in animals; biochemical preparations for medical or veterinary purposes being biological reagents for therapeutic use in animals; medicated animal feed; veterinary preparations for treatment of intestinal bacteria; pharmaceutical drugs being pharmaceutica...
General Information
Serial Number | 79403242 |
Word Mark | PETBEX |
Filing Date | Tuesday, July 9, 2024 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Tuesday, July 15, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Veterinary preparations for companion animals and non-companion working animals for treatment of inflammatory conditions, including metabolic, autoimmune, and geriatric diseases, and for preserving, supporting, or restoring the function of damaged tissues or organs to promote recovery and normal physiological function; veterinary vaccines; medicated skin treatment for animals in the nature of pharmaceutical preparations for animal skincare for the treatment of dermatitis and wound healing; food supplements for veterinary purposes; medical foodstuff additives for veterinary use for improving nutrition and immune function in animals; biological preparations for medical or veterinary purposes being biological reagents for therapeutic use in animals; biochemical preparations for medical or veterinary purposes being biological reagents for therapeutic use in animals; medicated animal feed; veterinary preparations for treatment of intestinal bacteria; pharmaceutical drugs being pharmaceutical preparations for the treatment of inflammatory conditions, including metabolic, autoimmune, and geriatric diseases, and for preserving, supporting, or restoring the function of damaged tissues or organs to promote recovery and normal physiological function. |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 29, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Brexogen Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | KR |
Trademark Events
Event Date | Event Description |
Thursday, August 29, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Wednesday, September 4, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Sunday, December 29, 2024 | ASSIGNED TO EXAMINER |
Friday, April 4, 2025 | REFUSAL PROCESSED BY IB |
Wednesday, September 4, 2024 | APPLICATION FILING RECEIPT MAILED |
Tuesday, February 11, 2025 | NON-FINAL ACTION WRITTEN |
Wednesday, February 12, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, March 19, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Wednesday, March 19, 2025 | REFUSAL PROCESSED BY MPU |
Tuesday, July 15, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, July 15, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Tuesday, July 15, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, July 15, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, July 15, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Tuesday, July 15, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, July 15, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |